FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913333413> ?p ?o ?g. }

• W2913333413 endingPage "414" @default.
• W2913333413 startingPage "414" @default.
• W2913333413 abstract "Hypertension is a major risk factor for the development of cardiovascular diseases. This study aimed to elucidate whether the natural product mixture No-ap (NA) containing Pine densiflora, Annona muricate, and Monordica charantia, or its single components have inhibitory effects on hypertension-related molecules in Angiotensin II (Ang II)-stimulated H9C2 cells. Individual functional components were isolated and purified from NA using various columns and solvents, and then their structures were analyzed using ESI–MS, 1H-NMR, and 13H-NMR spectra. H9C2 cells were stimulated with 300 nM Ang II for 7 h. NA, telmisartan, ginsenoside, roseoside (Roseo), icariside E4 (IE4), or a combination of two components (Roseo and IE4) were administered to the cells 1 h before Ang II stimulation. The expression and activity of hypertension-related molecules or oxidative molecules were determined using RT-PCR, western blot, and ELISA. Ang II stimulation increased the expression of Ang II receptor 1 (AT1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1), tumor growth factor-β (TGF-β) mRNA, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity and the levels of hydrogen peroxide (H2O2) and superoxide anion (•O2−) and reduced anti-oxidant enzyme activity. NA significantly improved the expression or activities of all hypertension-related molecules altered in Ang II-stimulated cells. Roseo or IE4 pretreatment either decreased or increased the expression or activities of all hypertension-related molecules similar to NA, but to a lesser extent. The pretreatment with a combination of Roseo and IE4 (1:1) either decreased or increased the expression of all hypertension-related molecules, compared to each single component, revealing a synergistic action of the two compounds. Thus, the combination of single components could exert promising anti-hypertensive effects similar to NA, which should be examined in future animal and clinical studies." @default.
• W2913333413 created "2019-02-21" @default.
• W2913333413 creator A5009351357 @default.
• W2913333413 creator A5011861620 @default.
• W2913333413 creator A5017130281 @default.
• W2913333413 creator A5020961447 @default.
• W2913333413 creator A5036838734 @default.
• W2913333413 creator A5048218030 @default.
• W2913333413 creator A5070431917 @default.
• W2913333413 creator A5074645251 @default.
• W2913333413 creator A5078381923 @default.
• W2913333413 creator A5088305725 @default.
• W2913333413 creator A5091575773 @default.
• W2913333413 date "2019-01-23" @default.
• W2913333413 modified "2023-10-14" @default.
• W2913333413 title "Inhibitory Effects of Roseoside and Icariside E4 Isolated from a Natural Product Mixture (No-ap) on the Expression of Angiotensin II Receptor 1 and Oxidative Stress in Angiotensin II-Stimulated H9C2 Cells" @default.
• W2913333413 cites W1522934134 @default.
• W2913333413 cites W1589548587 @default.
• W2913333413 cites W16306177 @default.
• W2913333413 cites W1963668163 @default.
• W2913333413 cites W1966000112 @default.
• W2913333413 cites W1968286569 @default.
• W2913333413 cites W1976332246 @default.
• W2913333413 cites W1987295645 @default.
• W2913333413 cites W1999236301 @default.
• W2913333413 cites W1999368517 @default.
• W2913333413 cites W2000182287 @default.
• W2913333413 cites W2009483350 @default.
• W2913333413 cites W2019491776 @default.
• W2913333413 cites W2032831426 @default.
• W2913333413 cites W2034131099 @default.
• W2913333413 cites W2034845795 @default.
• W2913333413 cites W2049321133 @default.
• W2913333413 cites W2052598919 @default.
• W2913333413 cites W2058245967 @default.
• W2913333413 cites W2060691678 @default.
• W2913333413 cites W2075658183 @default.
• W2913333413 cites W2080926483 @default.
• W2913333413 cites W2081527305 @default.
• W2913333413 cites W2082665191 @default.
• W2913333413 cites W2084412980 @default.
• W2913333413 cites W2094043004 @default.
• W2913333413 cites W2117185007 @default.
• W2913333413 cites W2147081693 @default.
• W2913333413 cites W2171345666 @default.
• W2913333413 cites W2214689356 @default.
• W2913333413 cites W2282914400 @default.
• W2913333413 cites W2293925129 @default.
• W2913333413 cites W2304841243 @default.
• W2913333413 cites W2319026788 @default.
• W2913333413 cites W2402754252 @default.
• W2913333413 cites W2475088339 @default.
• W2913333413 cites W2559825550 @default.
• W2913333413 cites W2602191315 @default.
• W2913333413 cites W2742282035 @default.
• W2913333413 cites W2743123742 @default.
• W2913333413 cites W2781568457 @default.
• W2913333413 cites W2788491563 @default.
• W2913333413 cites W2883530470 @default.
• W2913333413 cites W2889446891 @default.
• W2913333413 cites W2898254936 @default.
• W2913333413 cites W3003109697 @default.
• W2913333413 cites W3145527833 @default.
• W2913333413 cites W4362197812 @default.
• W2913333413 doi "https://doi.org/10.3390/molecules24030414" @default.
• W2913333413 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6384670" @default.
• W2913333413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30678135" @default.
• W2913333413 hasPublicationYear "2019" @default.
• W2913333413 type Work @default.
• W2913333413 sameAs 2913333413 @default.
• W2913333413 citedByCount "12" @default.
• W2913333413 countsByYear W29133334132020 @default.
• W2913333413 countsByYear W29133334132021 @default.
• W2913333413 countsByYear W29133334132022 @default.
• W2913333413 crossrefType "journal-article" @default.
• W2913333413 hasAuthorship W2913333413A5009351357 @default.
• W2913333413 hasAuthorship W2913333413A5011861620 @default.
• W2913333413 hasAuthorship W2913333413A5017130281 @default.
• W2913333413 hasAuthorship W2913333413A5020961447 @default.
• W2913333413 hasAuthorship W2913333413A5036838734 @default.
• W2913333413 hasAuthorship W2913333413A5048218030 @default.
• W2913333413 hasAuthorship W2913333413A5070431917 @default.
• W2913333413 hasAuthorship W2913333413A5074645251 @default.
• W2913333413 hasAuthorship W2913333413A5078381923 @default.
• W2913333413 hasAuthorship W2913333413A5088305725 @default.
• W2913333413 hasAuthorship W2913333413A5091575773 @default.
• W2913333413 hasBestOaLocation W29133334131 @default.
• W2913333413 hasConcept C104317684 @default.
• W2913333413 hasConcept C123915805 @default.
• W2913333413 hasConcept C126322002 @default.
• W2913333413 hasConcept C134018914 @default.
• W2913333413 hasConcept C170493617 @default.
• W2913333413 hasConcept C181199279 @default.
• W2913333413 hasConcept C185592680 @default.
• W2913333413 hasConcept C2776151105 @default.
• W2913333413 hasConcept C2776415932 @default.
• W2913333413 hasConcept C2777989768 @default.
• W2913333413 hasConcept C2779719074 @default.

• next